Edition:
India

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

27.19USD
19 Jul 2019
Change (% chg)

$-0.20 (-0.73%)
Prev Close
$27.39
Open
$27.36
Day's High
$28.28
Day's Low
$26.84
Volume
122,923
Avg. Vol
128,051
52-wk High
$29.00
52-wk Low
$11.45

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

Beta: --
Market Cap(Mil.): $1,731.94
Shares Outstanding(Mil.): 63.23
Dividend: --
Yield (%): --

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 30.29 34.03
EPS (TTM): -2.77 -- --
ROI: -68.89 13.03 12.70
ROE: -88.38 14.20 17.29

Earnings vs. Estimates